Efficacy and safety of abrocitinib in patients with moderate‐to‐severe atopic dermatitis with prior exposure to oral systemic immunosuppressants or biologic therapies: A post hoc analysis of the JADE clinical trials.

Autor: Gooderham, Melinda J.1,2 (AUTHOR), Ardern‐Jones, Michael R.3,4 (AUTHOR), Guttman‐Yassky, Emma5 (AUTHOR), Ameen, Mahreen6 (AUTHOR), Simpson, Eric L.7 (AUTHOR), Chan, Gary8 (AUTHOR), Biswas, Pinaki9 (AUTHOR), Chiu, Wing S.10 (AUTHOR), Watkins, Melissa9 (AUTHOR) melissa.watkins@pfizer.com
Zdroj: JEADV Clinical Practice. Dec2023, Vol. 2 Issue 4, p753-763. 11p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje